After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
BMY belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – General industry. The current market capitalization of Bristol-Myers Squibb Co is $102.16B. A total of 15.94 million shares were traded on the day, compared to an average of 13.69M shares.
In the most recent transaction, Hirawat Samit bought 4,250 shares of BMY for 47.58 per share on Apr 25 ’25. After the transaction, the EVP,Chief Med.Offr.,Drug Dev. now owns 83,513 company shares. In a previous transaction on Feb 20 ’25, BOERNER CHRISTOPHER S. bought 2,000 shares at 55.05 per share. BMY shares that Chief Executive Officer owns now total 104,626.
Among the insiders who bought shares, Hirawat Samit acquired of 1,823 shares on Feb 14 ’25 at a per-share price of $54.84. This resulted in the EVP,Chief Med.Offr.,Drug Dev. holding 63,932 shares of BMY after the transaction. In another insider transaction, Holzer Phil M sold 700 shares at $55.62 per share on Nov 04 ’24. Company shares held by the SVP and Controller now total 11,760.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Bristol-Myers Squibb Co pays an annual dividend of $2.44, resulting in a dividend yield of 4.86%, and it has a price to earnings (P/E) ratio of 18.85. BMY’s most recent ex-dividend date was 4.14% when it declared a $0.62 quarterly dividend that was paid in cash on 4/4/2025. Previously, the company paid the dividend on 1/3/2025 with an ex-dividend date of 4.38%. The BMY stock dividend was $0.62 per share in cash.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, BMY has a high of $63.33 and a low of $39.35.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BMY’s latest balance sheet shows that the firm has $17.22B in Cash & Short Term Investments as of fiscal 2021. There were $45.60B in debt and $21.87B in liabilities at the time. Its Book Value Per Share was $8.54, while its Total Shareholder’s Equity was $36.01B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMY is Buy with a score of 3.46.
